Rural Cancer Patients Get a Lifeline as Dresden Team Pilots Regional Tumour Network

In the rural stretches of East Saxony, a cancer diagnosis often comes with a second, quieter burden: distance. Patients living far from Germany’s maximum-care hospitals can face long journeys, fragmented communication between local doctors and specialists, and limited access to clinical trials that might offer them the newest surgical and systemic therapies. A team of researchers and clinicians from TUD Dresden University of Technology, the University Hospital Carl Gustav Carus, and the National Center for Tumor Diseases (NCT) Dresden has now published the detailed study protocol for an ambitious attempt to close that gap. The project, known as MISSION4Sax, is described in the open-access Journal of Cancer Research and Clinical Oncology as a multicentre pilot study designed to test whether a tightly networked, cross-sectoral cancer care model can work in routine practice in a medically underserved region.

The core of the model is a regional surgical indication tumour board hosted at the NCT Dresden. In modern oncology, treatment decisions are ideally made not by a single physician but by an interdisciplinary panel of surgeons, medical and radiation oncologists, radiologists, and pathologists who review each case together. In practice, however, patients treated in smaller rural hospitals frequently never reach such a board, because the expertise is concentrated in urban maximum-care centres. MISSION4Sax brings the board to the region: cases from participating rural hospitals and oncology practices are presented to the central panel, which then issues evidence-based, standardised treatment recommendations. The goal is that every patient in the network, regardless of postcode, receives a guideline-based therapy recommendation and, where appropriate, access to innovative surgery and clinical trials.

To translate those recommendations into coordinated care, the study develops and pilots standardised patient care pathways across three regional hospitals and two oncology practices in East Saxony. These pathways define, step by step, what should happen after a cancer diagnosis: which diagnostics are needed, when the tumour board should be consulted, how surgery or systemic therapy is scheduled, and how follow-up is organised. Pathways of this kind are intended to reduce waiting times, prevent duplication of examinations, and make deviations from guideline care visible and correctable. The pilot study is explicitly exploratory and prospective in design, following patients longitudinally to assess how the model performs under real-world conditions rather than testing the causal effectiveness of any single intervention.

Because a care model is only as good as the data infrastructure beneath it, MISSION4Sax places unusual emphasis on study management and digital coordination. The project builds its database on the infrastructure of the NCT Core Unit Registry Trial Platform, a professional research data system already used for other oncology registry studies. Targeted training programmes prepare staff at the participating sites for the new processes, from documentation standards to communication routines. Perhaps the most distinctive element is the deployment of so-called Flying Data Nurses: mobile study personnel who travel between the rural hospitals and practices to support coordination, data flow, and communication on site. This travelling workforce is meant to solve a chronic problem in multicentre research, where small institutions often lack dedicated study staff and data quality suffers as a result.

The researchers also widen the lens beyond clinical measurements. Patient-reported outcomes, collected systematically, complement the clinical data and capture how patients themselves experience the care pathway: their symptoms, quality of life, and satisfaction with coordination and information. In addition, routinely collected health insurance data will be used strictly as external reference material for a descriptive comparison with the MISSION4Sax cohort. The protocol is careful to specify that no individual-level data linkage will be performed with these insurance records, a design choice that reflects both privacy considerations and the pilot character of the study. A mixed-methods process evaluation will run alongside the entire project, combining quantitative indicators with qualitative interviews and observations to understand not just whether the model functions, but why, for whom, and under what conditions.

What the study will actually measure follows directly from its feasibility focus. The team plans to assess whether the care model can be implemented in routine care, whether patients and professionals find it acceptable, and how well the study infrastructure supports data quality. Secondary exploratory questions concern access to specialised care, waiting times from diagnosis to treatment, adherence to the defined pathways, coordination between sectors, and clinical as well as patient-reported outcomes. This framing matters scientifically: many promising care innovations fail not because the underlying medicine is wrong but because logistics, communication, and workload make them unsustainable. By testing feasibility, acceptability, implementation, and data quality first, MISSION4Sax follows the recognised logic of pilot studies that prepare the ground for later, larger trials of effectiveness.

The regional context gives the project its urgency. East Saxony combines mid-sized towns and villages with long travel distances to tertiary centres, and like many rural areas in Germany and across Europe it faces a shortage of specialists and growing pressure on hospital infrastructure. For surgical oncology in particular, where the choice of operation, the timing of neoadjuvant therapy, and the availability of high-volume expertise can decisively influence outcomes, the distance between a patient and a maximum-care centre is not a trivial inconvenience. Strengthening cancer care infrastructure, interdisciplinary cooperation, and digital systems, the authors argue, may support equitable access to high-value care in rural regions, so that the quality of treatment no longer depends on where a patient happens to live.

The study is registered in the German Clinical Trials Register under identifier DRKS00036134, with registration dated 30 June 2025. Ethical approval was granted by the Ethics Committee of TUD Dresden University of Technology, and the study will be conducted in line with the principles of the Declaration of Helsinki, with informed consent obtained from all participants. The project is funded by the German Federal Ministry of Research, Technology and Space under grants 01KD2402A and 01KD2402B, with the funding institution explicitly not interfering in any part of the study. The participating institutions named in the acknowledgements include Krankenhaus Bautzen, Asklepios-ASB Krankenhaus Radeberg, Klinikum Oberlausitzer Bergland in Zittau, and two oncology care providers in the region, forming the practical backbone of the network.

For the wider field of health services research, the protocol offers a template worth watching. It combines a central specialist resource, standardised pathways, professional data management, mobile study staff, and systematic patient-reported measures into a single regional architecture, and it documents the evaluation plan in enough detail that other regions could replicate or adapt it. If the pilot demonstrates that the tumour board, the pathways, and the trained staff improve care quality and collaboration across sectors, the model could inform how rural cancer networks are built well beyond Saxony. Conversely, if the process evaluation reveals friction points, whether in documentation burden, communication delays, or staff capacity, those findings will be equally valuable, identifying precisely where investment is needed before the model is scaled.

The first results will show whether a Flying Data Nurse with a laptop and a central tumour board can do what decades of structural reform have struggled to achieve: make excellent cancer surgery and trial access a matter of course, rather than geography, for patients in the countryside. As the authors conclude, the proposed tumour board, patient pathways, and trained staff may improve care quality and collaboration across sectors, and the pilot study now underway in East Saxony will provide the evidence on whether that promise holds in the demanding reality of routine clinical care.

Subject of Research: A multicentre pilot study protocol for cross-sectoral oncological care, data integration, and rural-urban networking in East Saxony

Article Title: Optimized surgical treatment and study management for oncology patients in East Saxony (MISSION4Sax): study protocol of a multicentre pilot study

Article References: Richter, C., Döring, A., Berg, F., Roost, M., Hasselberg, A., Martin, C., Schlieter, H., Piontek, D., Schoffer, O., Schmitt, J., Weitz, J., Krause-Jüttler, G., & Kirchberg, J. (2026). Optimized surgical treatment and study management for oncology patients in East Saxony (MISSION4Sax): study protocol of a multicentre pilot study. Journal of Cancer Research and Clinical Oncology, 152(9), Article 173. https://doi.org/10.1007/s00432-026-06599-2

Image Credits: AI Generated

DOI: 10.1007/s00432-026-06599-2

Keywords: surgical oncology, multidisciplinary tumour board, patient pathways, health services research, rural healthcare access, cancer care networks, pilot study, patient-reported outcomes, data quality, Germany, clinical trials, health equity